Business Context and Reporting Period
Company: OKYO Pharma Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: September 8, 2026
Context: The filing announces the Company's participation in the Cantor Global Healthcare Conference scheduled for September 9-11, 2026. The announcement is furnished as Exhibit 99.1 and is incorporated by reference into the Company's Registration Statement on Form F-3.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely as a notification of an upcoming conference appearance and does not contain financial statements or operational data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing contains no comparative data versus prior periods.
Guidance, Outlook, and Risks
Outlook: The Company intends to present at the Cantor Global Healthcare Conference.
Risks and Contingencies: The filing text does not provide specific details regarding risks, contingencies, or unusual items. It notes that the information in the attached exhibit is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the content of the attached Exhibit 99.1 (News Announcement) for specific details on the conference presentation.
- Confirm the Company's participation schedule for the Cantor Global Healthcare Conference (September 9-11, 2026).
- Review the Company's Registration Statement on Form F-3 (Reg. No. 333-293145) for the most recent financial data, as this 6-K does not include it.